Researchers said in their study that vitamin D supplements could reduce the rate of ICU penetration due to Kovid-19.
In Spain, 76 patients who tested positive for Covid-19 were studied.
Researchers created two covalents of patients. Both were given the same therapy based on hospital protocol.
However, one group was also given a daily calcified supplement, also known as 25-hydroxyvitamin D.
The findings suggested that the supplement is a metabolite of vitamin D that appears in the blood and may help determine future health risks.
The study found that out of the group of 50 patients receiving the supplement, only one was admitted to the ICU.
The study also found that patients who received the supplement were discharged from the hospital without any complication or risk of death, which was caused by Kovid-19.
Meanwhile, the researchers mentioned that 13 of the 26 patients in the second group were admitted to the ICU. Two of these patients eventually lost their lives, and the other 11 were discharged from the hospital.
The authors of the study said in a statement, “Our pilot study showed that the administration of a high dose of calcidiol or 25-hydroxyvitamin D, the main metabolite of the vitamin D endocrine system, proved the need for ICU treatment of hospitalized patients. Has reduced significantly. Kovid 19. ”